Separating From The Crowd

Work and think in isolation

Intuition does not ‘collaborate’

If you’re serious about your growth with market analysis and trading, at some point in the journey, you’ll discover this fact:

The most successful and effective market speculators operate alone.

Livermore had his office with the ticker, ‘board boys’, and not much else.

Wyckoff (from his autobiography) refused over and over the overtures of his wealthy clients to establish a more personal relationship.

The late David Weis was the same; managing his own account.

One difference with him; he provided a mentoring service that passed on his valuable insight.

It was a steal of a price (back in 2011) … just $1,500.

Personal Anecdote (being mentored by Weis):

It was April, of 2011:

As Weis interviewed me on the phone, asking all sorts of questions about my background (engineering), my parents (my late father, a Yugoslav national, shot by Germans in an attempted execution during WWII), and my trading objectives, it became clear to me, I would pay whatever price necessary to gain an audience with him.

This all took place before his website was complete and before his book was published. It was sort of a ‘golden time’.

Stretched Growth:

Weis traded the futures markets. If I was to be mentored by him, I would need to get up to speed and trade futures as well.

I knew almost nothing (except they were highly leveraged) about those markets. However, I was determined to learn very quickly.

During the phone interview, which lasted maybe forty minutes to an hour, he did not mention (and I did not ask) the cost of his services.

As the call progressed, I was literally getting sick with anticipation.

Coming to a close, almost absentmindedly, he said: ‘It’ll be $1,500’.

I fully expected him to say, and would have gladly paid $5,000 or more … which was the going rate for a typical trading course.

He then ‘suggested’ that I open a futures account; our mentoring sessions would start the next week.

Fast Track:

After that call, three things happened in quick succession.

First: A check (he was old-school) was mailed off to him in Boston so that it would clear before the next week.

Second: I contacted TradeStation and got their futures paperwork to open an account. That happened quickly and $15,000 (an amount suggested by Weis), was wired to the account.

Third: Buy the time of the first session, I already had the futures account set up and had determined what markets I would be trading: The LIFFE mini-futures (now part of ICE Futures Europe) for gold and silver.

On The Fly:

One last thing about trading futures and learning quickly.

I noticed about two weeks into trading silver, the volume on the contract I was in, started to drop off.

I did not understand why the liquidity was drying up … that is, until I checked my e-mails.

Turns out, I was about to ‘take delivery’, and pay $37,000 for a bar of silver if I did not exit the contract (that day).

The entire time with Weis was a growth experience. Very painful most of the time as knowledge had be acquired on the spot.

During our sessions, I would have the phone to my ear and be feverishly taking ‘screen shots’ of his computer (via gotomeeting,com) as he progressed through the session.

This link is probably as close as one will come to a typical mentoring session.

No Group Consensus:

Going to the link and watching for even a few minutes, it’s obvious this type of analysis is in a class of its own.

Nowhere in the video does he mention P/E ratios, Sales-to-Book or any number of useless metrics.

Deciding to pursue this type of trading, will of itself, separate you from the crowd.

The mainstream financial press will never present this level of detail. The general pubic does not have the intellectual capability or discipline to really get down and craft this skill.

Of course the financial media, YouTuber’s and the like, are all too happy to cater this (mediocre) crowd by showing their supposed prowess on dissecting financial reports and/or pontificating on the latest Fed speech.

Little does the public know, this type analysis (fundamental metrics) is just a ruse; a distraction promulgated over the life of the markets to distract and disable the masses.

The fact that ruse keeps going, is proof in itself of its effectiveness.

Which brings us, once again, to biotech.

SPBIO (LABD): Analysis

In this case, which could be one of a kind in history, the fundamentals are important.

Those in the biotech sector have intentionally (depending on whose data is used) fatally poisoned millions if not billions.

Their natural immune systems have been forever destroyed and their life expectancy drastically shortened.

Even so, this fundamental backdrop must not cloud interpreting the market behavior at hand and the Wyckoff analysis.

We’ll start as Weis does in the video link, with an un-marked chart. Daily close of inverse fund LABD:

Next we’ll show how the right side action is alternating its behavior:

At this juncture, the market is not able to retrace.

Price action from the last intermediate low in late June, has formed a double, then single, and then no bottom.

Adding in the repeating trendline study, LABD is currently near a contact point on the right side trend:

Price action itself points to more downside for SPBIO (LABD higher).

With the overall markets closing poorly on Friday, the implication is for lower action in the coming week.

Consumer All Done:

The post on Friday, showed how the consumer is literally spent.

About an hour later, Steven Van Metre came in with additional details.

Then, couple that with Dan’s (iAllegedly) assessment: “The Party’s Over”; the pressure continues to build.

We might take the example of lumber futures as a model for upcoming price action; essentially, straight down -66.3%, in 48 trading days.

Wistful Conclusion:

David Weis is now gone (passed away last year).

After listening to his voice once again, I have let it personally admonish me to remain focused and diligent.

Even a decade after our mentoring sessions, with focused effort, the search for mastery is never ending.

To borrow a quote from Oswald Chambers: “One must determine to be limited and focus their affinities.”

We’re at a critical time in world history and that’s not overstated.

Our conditions have brought so many cowards to the fore.

In a way, it’s a tremendous public service.

It’s clear to see who is leading and who is cowering in place.

If anyone has a hope of surviving (even prospering) in this environment, for some it will be taking control of their own market decisions; separating themselves from those who want them to remain ignorant.

Stepping out into the raw edge of life, has no guarantee of success.

However, what is guaranteed, is stretching of oneself into a new level of thinking, experience, and wisdom.

That, is its own reward.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

‘Greed is Good’

11:53 a.m., EST

Old Fashioned Greed Saves The Day?

After BA pilot fatalities were confirmed, at least one airline is backing off from insisting their pilots are injected.

Some adverse reactions linked above, occurred in-flight; the pilot was incapacitated.

“Is there a pilot on-board?”

That could become a frequent call through the cabin intercom in the months … even years to come.

The bottom line implications are obvious.

The response to ‘back-off’ probably has nothing to do with safety and more to do with protecting those executive stock options.

Which brings us to the markets.

Analysis: SPBIO (LABD)

The last update for biotech said it was ‘about to get real’. So, it has.

Looking at SPBIO inverse fund LABD, we have the familiar trend lines:

The market itself says it wants to follow this trend.

Pulling out to the weekly, we get what seems to be an incredible picture.

At the beginning of the trade, the short position in SPBIO, via LABD (not advice, not a recommendation), had an exit time-frame during the second, or third week of October.

From an empirical and seasonal standpoint, that’s when on-going downtrends tend to reach their lows.

Already Baked In:

Various numbers are bandied about as to how many have been injected.

One estimate is 2-Billion, world-wide (Dr. Coleman if memory serves).

Total population at 7.9-Billion; 2-Billion, equates roughly to 25%

No matter what happens, de-population is already baked-in.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Biotech: Now, It Gets Real

Biotech reversal

No one is looking

The only way for price action to even hope of printing a Fibonacci series (daily chart), is when virtually no one is looking.

A quick YouTube search of “Biotech analysis“, turns up these links:

Best Biotech Growth Stock to Buy Now?? : Vertex Pharmaceuticals (VRTX) Stock Analysis

3 Cheap Biotech Stocks With 100% Upside in 2021

Biotech analyst on CRISPR technology: Early data is very promising

Those three, are the most recent.

Looking at each, none of them even hint things could go wrong.

To be really cynical (and probably correct), the senior trading professionals may know this sector’s at risk of implosion.

They task junior employees to cover it; attempting to talk it up.

Analysis: SPBIO

Moving on to inverse fund LABD, we have Fibonacci correlation on two time frames:

In addition, from a Wyckoff standpoint, we’re in spring position on the weekly and daily time frames.

All of this points to high probability (not advice, not a recommendation) that biotech and specifically the weaker SPBIO, has pivoted to the downside (LABD higher).

Naming Names:

A couple of days ago, we had Dr. Yeadon (former Chief Scientist, Pfizer) absolutely grilling and eviscerating his interviewers, covered here.

Then, we have Dr. Coleman deciding to name, names.

Now, it’s getting real.

With this type of high-level pressure being applied from internationally known and respected (real) heroes, one has to think, it can’t be long before the lie is fully exposed; blowing the entire sector, wide open.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Random Notes

The usual suspects for the week

No. 1

Next Up: Power Outage

National Guard’s in training for nationwide power outages.

The June 26th post, finished with this quote:

‘Most people think the worst is over when it’s not even started.’

That exemplifies the mindset required. This economic and societal decline is going to be a very long ordeal.

Surviving it, is like the two guys spooking a bear in the woods.

“We’re not going to out-run him” one says. The other guys says, “I don’t need to run faster than him … just faster than you”.

You don’t need to have 5-years of food stored. You only need as much to outlast the majority who are not prepared.

No. 2

Neo Feudalism

It’s been a while since this concept has been discussed. Our last post on the subject is here.

Now, we have this site giving us another view of the plan as it moves forward.

Self-employment is one answer to avoid being sucked into serfdom.

No. 3

Grease Plant Destroyed

Largest grease plant in the U.S. destroyed by fire.

So far we have:

Ship blocks Suez Canal for six (that’s right, 6) days.

Then, a 557 ft. ship carrying auto parts, sinks off coast of Japan.

Now, we have a grease plant fire.

Want grease, auto parts or food?

Get injected and we’ll put it all back to ‘normal’.

No. 4

Idiots Suffer More

There’s no joy watching others suffer.

Those of us who just want to ‘wake up others’, want only that; meaning, somehow, you’re able to pull back the veil. They now have eyes to see and ears to hear.

However, some seem to be under a spell.

Even after being diagnosed with a known side effect from injection, the truth is still mocked (time stamp 0:53 in the text).

No. 5

“Churches … have basically, checked-out”

Jerimiah Babe calls it straight at time stamp: 16:24

‘The Church’ had its opportunity way back in March of 2020.

That was the time to call on supernatural protection to ward off (what this site calls ‘the speck’ to avoid censorship) any negative effects of what we now know, was a fake enemy.

What we have instead, is this.

Let’s review for just a second:

“But the men marvelled, saying, What manner of man is this, that even the winds and the sea obey him!”

Does the master of the universe, the maker and sustainer of all things, really need a ‘man-made’ injection?

No. 6

Expired Lethality

It’s bad enough to line up and voluntarily get injected with a lethal compound.

Now, I’ve got to worry if that lethality has “expired”.

If it’s expired, is it more lethal, or less?

I want my money’s worth!

No. 7

Texas Heatwave … just another lie

The article at this link would have you believe it’s sweltering in Texas.

The short answer is no.

Not only no, but summer in Texas, had a late start.

The morning of Labor Day weekend, scheduled opening for the pool at city park, was 68-degrees.

The high for Labor Day Sunday, in Ft. Worth Texas, was 14-degrees colder, than last year.

No. 8

Pharmacist tells it like it is

Refuses to be part of the execution squad.

No. 9

Lions and tigers and Delta … Oh my!

Catherine Austin Fitts provides insight. Delta ‘variant’, is really ‘injury’ from the injection.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Jab if you do … Jab if you don’t

Those injected, thought they could travel

If you’re a leader, business owner or entrepreneur, dealing with idiots is probably the most frustrating part of running a business.

The leader has an absolutely thankless job most of the time.

However, there are times where being someone that can think, act, and be resistant to the criticisms of the crowd (‘double-jabbed zombies’ as Dr. Vernon Coleman calls them), pays off in spades.

At least we don’t have to put up with being played as we see here.

As we move forward to fall and winter, we’ll find out just how important resisting the peer pressure of the (double-jabbed) crowd may be.

On the practical side, David Knight interviews Catherine Austin Fitts on steps that can be implemented for personal financial and legal protection.

She touches on a subject that’s been covered several times on this site; that is, killing-off your customers is not good for future business.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

United Airlines … Signals Sell

3:13 p.m., EST

There’s no such thing as corporate ‘leadership’.

At this point, especially after witnessing the ‘lock-step’ positioning of major corporations over the past year, one thing is obvious:

They’re all operating in concert.

The coordinated message is that everything’s getting back on track. No need to worry.

See how ‘normal’ things are? Big companies are even ‘planning’ for the future. Stay calm and take no (preparatory) action.

Indian Summer:

The reality is, just as this link suggests, we’re in an Indian Summer. That is, we’re between two extremes.

The past year can be viewed as the summer heat. Then, we’ve just had a break (advent of fall/winter) with restrictions being lifted … but soon the figurative and literal winter will come.

Think that’s a bit much? Well, let’s just take a look at one item.

The video in the link above, mentions the need for ‘body bags’; that we’ll run out … sounds insane.

Well, here they are … all ready to go.

Which brings us to the markets.

Chart Analysis, UAL:

The long term, Quarterly chart shows the extent of the technical damage.

The 80% drop could be the beginning of a multi year (maybe decades long) decline.

If it was a crash (like lumber futures), it will have the typical crash-like structure.

That is: An initial swift, decisive decline; followed by retracement which then rolls over into a sustained and long term move lower.

Meanwhile, the S&P 500, is hovering at its all-time-highs.

Not only has UAL not made a new all time high (posted way back in December of 2018), the weekly chart shows it’s formed a terminating wedge.

At this point, it’s ‘rolling out’ of that wedge indicating sell or sell short; Not advice, not a recommendation.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Deep Dive: Gold Reversal

Gold Miner’s GDX

Fibonacci Projection

Rule of Alternation

Wyckoff analysis was used to identify the GDX up-thrust, reversal condition.

Nine trading days later, GDX is down a stiff -11.7%, from the analysis location.

It’s down -14.9% from its interim high set on May 19th.

What happens next?

This site offers a different perspective (more thoughtful, perhaps) than ‘stacking’ precious metals as high as possible.

Thoughts such as, major infrastructure disruptions (and more) are likely:

That includes nationwide power outages, food transport interruptions (or cancelled outright) along with massive ‘speck’ injected casualties (estimated past 100,000), see this report.

The very last thing you’ll need in that environment, is a stack of metal (not advice, not a recommendation).

Personal anecdote, skip to GDX Chart, if not interested.

These updates are originating from the North-Central area of Texas (DFW). When the historic cold snap rolled through this past February, the power went out repeatedly.

The first thought was not: “I’m sure glad I have my stack of silver to get me through”

No. The thinking was (in this order):

Food, water (water was second as there was plenty of it just outside as snow), munitions and ‘delivery mechanisms’, cash in case the gas station was operational … which is was not and then lastly, heat.

The location was using natural gas for heating and was available as long as there was power

Precious metals were nowhere on the list … not even considered. They had nothing to do with the situation at hand.

Precious metals come later … after the famine.

GDX Chart:

The original analysis from June 8th, is below:

Subsequent trade action (including the original notes):

Weekly chart showing Fibonacci downside projection to level(s) mentioned frequently by Steven Van Metre.

In the chart above, note the choppy action leading down to the most recent upside pivot (early March). That area expanded below:

If we’re in a reversal to much lower levels, the market tends to alternate.

It was choppy and overlapping action from the highs in August of ’20 to the March ’21, low.

Thus far at the pivot high in late May, its been essentially straight down.

With the planned outages discussed above, precious metals may become (temporarily) irrelevant.

If or when that happens, it may be time to consider a ‘stack’.

Of course, by then, no one will want to buy (and spend their worthless fiat cash) for risk of starving to death. This is how markets work.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Deadliest in World History

3:37 p.m., EST

Injections, Deadliest Ever

Forced Compliance

Biotech Danger Point

By this time, it’s no secret.

The ‘speck’ injections as we call them, have been proven to be the deadliest in world history.

Even with manipulating data by deleting deaths, delaying updates, pressuring medical professionals not to report, the data at this link paints a stark picture.

For reasons likely to be revealed later, major corporations are ‘requiring’ their employees to comply.

Not only that, in the link above it’s the clients as well. One has to wonder, who are ‘clients’ beneficiaries?

Before we leave the topic and move on to the chart, one of the ‘features’ of the injection, is sterilization.

No more employees. No more clients. No more future clients. Somehow that’s an effective business model.

Finally, a cursory review of the local ‘certified’ financial advisers and their websites has not one word about what’s really going on.

Do these people think by avoiding the truth, somehow they’re going to increase their business?

One major nationwide adviser/broker even has (in print, mind you) that ‘we’re going to have the best recovery ever!’

What are they going to say when there’s a “no bid” market and nobody can get in or out?

Crisis will create opportunity for leadership; at this point, there’s not much if any in the financial sector (i.e. ‘best ever’, above).

When the big melt-down hits, leadership’s not coming from the ranks of the ‘compliant’ or the enforced mediocrity of the ‘fiduciary’.

Therefore, we can all take our cue; like this Irish couple who took it upon themselves, to separate from the crowd and escape quarantine.

With that in mind, on to the markets:

Analysis, Biotech

As we head towards the close with about twenty minutes left, the S&P 500, has posted an all-time high.

Biotech, SPBIO and IBB, are still well below their highs but are nonetheless at a point of instability with today’s action.

As the Hourly chart of LABD shows, we’re at the danger point and in spring condition:

A push back into the range above support, is significantly bullish for LABD and bearish for SPBIO.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Deep Dive: Biotech

Biotech Reversal

Downside Projections

Nuremberg 2.0

For what seems the longest time, a recurring focus of this site has been the biotech sector.

Specifically, the IBB (ETF) and SPBIO (Index).

There’s good reason for that. In this update, we’ll go deeper into the downside opportunity.

Biotech Reversal:

SPBIO, topped out on February 9th this year. The IBB (ETF) topped one day later.

Both went on to form a Quarterly reversal bar; indicating a long term change in character.

Of the two, SPBIO has showed more weakness having posted monthly lower lows for three successive months.

That relative weakness over the IBB index, has resulted in focusing on the inverse of SPBIO; specifically the 3X inverse, LABD.

Working with leveraged inverse funds is only profitable on a short-term basis or when the underlying index is in a persistent down-trend.

Otherwise, typical market chop results in value erosion of the inverse fund (not advice, not a recommendation).

For the reasons discussed in the last section below (Nuremburg 2.0), we’re anticipating the index to have a sustained and persistent drop to much lower levels.

Downside Projections:

Going way back to Reminiscences of a Stock Operator and the Wyckoff Stock Market Institute training materials, both in their own way indicated a speculative position was only entered if there was sufficient potential.

Livermore’s 10-points or more and Wyckoff’s cause and effect

In Wyckoff’s case, the ’cause’ was price action congestion built up in the P&F chart.

The ‘effect’ was the resulting move.

Which brings us to now:

Many times on this site, we’ve said biotech has built up congestion in a way, when it reverses and begins its decline, price action itself will create lower targets.

We’ll present two charts showing how that’s happening.

The first P&F chart in this update and provided below, has a projected downside target for IBB around, 116 – 120 area:

Note, the downside is not to scale as the real location is far below the noted area.

Biotech IBB, then went on to post lower action. That in turn has resulted in an updated downside target:

Once again, the downside is not to scale.

It’s apparent, as IBB heads lower, it successively builds lower targets and it’s only (potentially) just getting started.

The weekly chart of IBB below, spells it out:

If and when IBB price action gets to the initial targets, it enters a congestion area that will (by that time) be over seven years wide.

If the trend is still down, that congestion in turn would target even lower levels.

The “-80%” interestingly enough, comes from a quote by Steven Van Metre at this link.

That 80% drop also corresponds to a downside Fibonacci (not shown) projection of 423.6%, on the above chart.

Nuremberg 2.0

This phrase has become so ubiquitous you can do a search for it.

So far, not a single mainstream financial site or YouTuber (still on that platform) has mentioned this fact in their analysis.

The speck injections are mass genocide and intended as such.

Two recent events resulting from injections are here and here.

If all of a sudden, injected pilots can’t fly (the first link), how are goods going to be transported?

Not generally known to the public, commercial air-transport is also used to haul freight (while carrying passengers).

Exactly how all of this (world crime) will break is unknown.

If and when it does, the result in the biotech sector as well as equities in general, could be successive air-pockets all the way down.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Moderna “Throw-Over”

11:35 a.m., EST

Price action posts new weekly low

Now, back into the (wedge) range

In a situation that’s straight out of any typical trading text: ‘When a market goes into a throw-over and then enters back into the range, it’s a classical analysis sell signal’ (not advice, not a recommendation).

That’s where Moderna (MRNA) is now.

Moderna’s the ‘chief cook and bottle washer‘ for the world-wide kabuki theater. So, we’re using it as a proxy for the biotech sector as a whole.

Separately, biotech index IBB, is retracing but has not posted a new daily low.

Inverse SPBIO fund LABD, has formed an hourly reversal bar and looks to be forming a daily reversal bar. As of this update, it has yet to post a new daily high.

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.